Aphria Inc. produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients, health professionals, and veterans. The company sells its products through its online store or phones, as well as engages in the wholesale shipping of cannabis plant cuttings and dried buds to other licensed producers. Aphria Inc. is headquartered in Leamington, Canada.
Industry, Sector and Symbol
Stock Exchange TSE
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
SymbolTSE:APH
CUSIPN/A
PhoneN/A
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins75.91%
Return on Equity7.63%
Return on Assets6.72%
Miscellaneous
EmployeesN/A
Outstanding Shares203,966,000
Market CapC$2.31 billion
Aphria (TSE:APH) Frequently Asked Questions
What is Aphria's stock symbol?
Aphria trades on the Toronto Stock Exchange (TSX) under the ticker symbol "APH."
How were Aphria's earnings last quarter?
Aphria Inc (TSE:APH) posted its quarterly earnings results on Wednesday, August, 1st. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.02) by $0.02. The company earned $12.03 million during the quarter, compared to the consensus estimate of $11.22 million. Aphria had a net margin of 75.91% and a return on equity of 7.63%. View Aphria's Earnings History.
When is Aphria's next earnings date?
What price target have analysts set for APH?
0 brokers have issued 12-month target prices for Aphria's stock. Their forecasts range from C$24.50 to C$25.00. On average, they expect Aphria's stock price to reach C$24.75 in the next twelve months. This suggests a possible upside of 25.6% from the stock's current price. View Analyst Price Targets for Aphria.
Who are some of Aphria's key competitors?
Some companies that are related to Aphria include Valeant Pharmaceuticals Intl (VRX), Canopy Growth (WEED), Aurora Cannabis (ACB), STADA Arzneimittel (SAZ), Hikma Pharmaceuticals (HKMPY), Hikma Pharmaceuticals (HIK), MedReleaf (LEAF), Knight Therapeutics (KHTRF), Hydropothecary (THCX), OrganiGram (OGI), Supreme Cannabis (FIRE), Weed (BUDZ), OrganiGram (OGRMF), Medical Marijuana (MJNA) and Benchmark (BMK).
Who are Aphria's key executives?
Aphria's management team includes the folowing people:
- Mr. Victor Neufeld, Chair of the Board of Directors, CEO & Pres (Age 64)
- Mr. Cole Cacciavillani, Co-Founder, COO, VP of Growing Operations & Director (Age 63)
- Mr. John Cervini, Co-Founder, Chief Agronomist Officer, VP of Infrastructure & Technology and Director
- Mr. Carl A. Merton, Chief Financial Officer
- Ms. Megan McCrae, Director of Marketing
How do I buy shares of Aphria?
Shares of APH and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Aphria's stock price today?
One share of APH stock can currently be purchased for approximately C$19.70.
How big of a company is Aphria?
Aphria has a market capitalization of C$2.31 billion.
What is Aphria's official website?
MarketBeat Community Rating for Aphria (TSE APH)
MarketBeat's community ratings are surveys of what our community members think about Aphria and other stocks. Vote "Outperform" if you believe APH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe APH will underperform the S&P 500 over the long term. You may vote once every thirty days.
